Anlon Healthcare Completes Share Swaps for Acquisitions of Stakes in Apiqo Organics and Bizotic Lifescience

Anlon Healthcare Completes Share Swaps for Acquisitions of Stakes in Apiqo Organics and Bizotic Lifescience​

Anlon Healthcare Limited convened its Board of Directors meeting on August 13, 2026, approving several key strategic outcomes, including the adoption of two significant share swap agreements. These transactions enable the company to acquire substantial stakes in two related entities: Apiqo Organics Private Limited (AOPL) and Bizotic Lifescience Private Limited (BLPL). The board meeting also reviewed audited financial statements for FY 2026 and handled matters pertaining to corporate governance, including director appointments and capital structure updates.

The Board approved the acquisition of up to 44.94% shareholding in Apiqo Organics Private Limited (AOPL) under a share swap agreement dated August 8, 2026. The total purchase consideration for AOPL amounted to Rs. 1,165,179,600/- at a price of Rs. 258/- per equity share. This acquisition will be discharged by the issuance and allotment of up to 6,52,76,283 fully paid-up equity shares of Anlon Healthcare, with each share having a face value of Rs. 02/- and being issued at Rs. 17.85/=.

Simultaneously, the company approved the acquisition of up to 47.41% equity shareholding in Bizotic Lifescience Private Limited (BLPL). The total purchase consideration for BLPL is approximately Rs. 367,840,000/- at a price of Rs. 160/- per equity share. This transaction will be completed through the issuance and allotment of up to 2,06,07,334 fully paid-up equity shares of Anlon Healthcare, with each share having a face value of Rs. 02/- and being issued at Rs. 17.85/=.

The company's board also took steps to strengthen its corporate structure and governance:

• Capital Expansion: The Board reviewed the increase in authorized share capital from Rs. 1,100,000,000 (Rupees One Hundred and Ten Crore Only) to Rs. 1,300,000,000 (Rupees One Hundred Thirty Crore Only), which is subject to approval by shareholders at the forthcoming annual general meeting.
• Governance: The board regularized the appointment of Mr. Kishan Vinodkumar Raja as a Non-Executive and Independent Director, replacing his position as an Additional Non-Executive & Independent Director effective February 09, 2026. Furthermore, Mr. Parth Sanjaybhai Udani was appointed as the Internal Auditor for the financial year 2026-2027.
• Director Consideration: The board considered the re-appointment of Mr. Punitkumar Rameshbhai Rasadia (DIN: 06696258) as Chairman & Managing Director, who retires by rotation.

Key Transaction and Corporate Details Summary​

The details of the acquisitions and related party transactions approved during the meeting are summarized below:

Related Party Transactions and Corporate Developments​

The board also reviewed material related party transactions (RPTs) involving the company and its subsidiaries with Apiqo Organics Private Limited, Bizotic Lifescience Private Limited, and Anlon Medicos Private Limited. These RPTs include both sales/purchases of goods and proposed investments in shares, conducted at an arm's length basis.

In addition to these activities, the meeting established key timelines for corporate events:

• Annual General Meeting (AGM): The AGM is scheduled for Saturday, September 05, 2026, and will be held via Video Conferencing (VC) / Other Audio Visual Means (OAVM).
• E-voting Period: The e-voting period for the company commences on Wednesday, September 02, 2026, and ends on Friday, September 04, 2026.
• Book Closure: The Register of Members and Share Transfer Books will be closed from Saturday, August 29, 2026, to Friday, September 04, 2026.

AHCL Stock Price Movement​

On Thursday, Anlon Healthcare Limited shares edged higher to close at ₹14.25 after gaining 0.14%. The stock traded with a total volume of 1.31 million shares, which saw prices fluctuate between the day's low of ₹14.10 and high of ₹14.43.